Objective To compare the clinical features and follow-up results of systemic lupus erythematosus (SLE) between boys and girls. Methods A retrospective analysis was performed for the clinical data of 79 children (18 boys and 61 girls), aged ≤ 14 years, who were diagnosed with SLE from 2008 to 2018. The boys and the girls were compared in terms of initial and major clinical symptoms, injury of organs/systems, related laboratory markers, and follow-up results. Results As for the initial and non-initial symptoms, fever had the highest incidence rate in the boys, while facial erythema had the highest incidence rate in the girls. The boys tended to develop renal injury and hematological damage (P < 0.05), with a significantly higher incidence rate of proteinuria than the girls (P < 0.05), while the girls tended to develop joint pain (P < 0.05). There were high abnormal rates (>80%) of anti-nuclear antibody, dsDNA, complement C3, and erythrocyte sedimentation rate in both boys and girls (P > 0.05). The boys had a significantly higher disease activity than the girls at the first visit and in year 9 of follow-up (P < 0.05). A one-month to ten-year follow-up showed that among the boys, 3 were lost to follow-up, 1 died, 7 were well controlled but required oral administration of large doses of hormones or immunosuppression, 2 progressed to chronic renal failure, and 1 developed lupus encephalopathy. Among the girls, 3 were lost to follow-up; 5 died; 34 were well controlled, among whom 5 were maintained on oral prednisone acetate with a dose of <10 mg, 1 was withdrawn from the drug for 1 year, and 2 were withdrawn from the drug for 2 years; 4 developed lupus encephalopathy; 1 developed depression and anxiety and had suicidal tendency in the 7th year after disease onset; 2 experienced impaired vision, blurred vision, and chloropsia; 1 developed a vascular necrosis of both femoral heads in the 3rd year of hormone administration. Conclusions There are differences in clinical features, several laboratory markers, and prognosis between boys and girls with SLE. Boys tend to have a high severity at disease onset, develop renal injury and hematological damage, and have poor long-term prognosis, while girls tend to have joint involvement.
Key words
Systemic lupus erythematosus /
Sex /
Clinical feature /
Follow-up /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Oku K, Atsumi T. Systemic lupus erythematosus:nothing stale her infinite variety[J]. Mod Rheumatol, 2018, 28(5):758-765.
[2] Rees F, Doherty M, Grainge MJ, et al. The worldwide incidence and prevalence of systemic lupus erythematosus:a systematic review of epidemiological studies[J]. Rheumatology (Oxford), 2017, 56(11):1945-1961.
[3] 苏荣, 唐秀英, 席向红, 等. 男性儿童与成人系统性红斑狼疮的临床分析[J]. 中国全科医学, 2016, 19(9):1095-1098.
[4] 周燕青, 郭茹茹. 儿童系统性红斑狼疮预后的影响因素研究进展[J]. 国际儿科学杂志, 2016, 43(10):743-747.
[5] 徐珍娥, 李秋. 不同性别系统性红斑狼疮患儿的临床特点[J]. 中华实用儿科临床杂志, 2009, 24(9):656-658.
[6] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9):1725.
[7] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum, 1992, 35(6):630-640.
[8] Couture J, Silverman ED. Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2016, 28(5):488-496.
[9] 李改静, 刘慧敏, 李小兵. 雌激素对系统性红斑狼患者病情活动的影响[J]. 系统医学, 2017, 2(19):164-168.
[10] Artim-Esen B, Şahin S Çene E, et al. Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 tertiary centers in Turkey[J]. J Rheumatol, 2017, 44(5):619-625.
[11] Molina-Ruiz AM, Lasanta B, Barcia A, et al. Drug-induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine[J]. Australas J Dermatol, 2017, 58(1):e20-e22.
[12] 章瑜, 段晓岷, 梅海炳. 儿童系统性红斑狼疮骨梗死的影像表现[J]. 中国骨伤, 2018, 31(3):272-275.
[13] Groot N, de Graeff N, Marks SD, et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis:the SHARE initiative[J]. Ann Rheum Dis, 2017, 76(12):1965-1973.
[14] Lee PY, Yeh KW, Yao TC, et al. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus-a 20-year experience in Asia[J]. Lupus, 2013, 22(14):1534-1540.
[15] Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus[J]. Medicine (Baltimore), 2006, 85(3):147-156.
[16] 张兴宗, 林云, 邹映东. 系统性红斑狼疮患者自身抗体与补体检测结果分析[J]. 国际检验医学杂志, 2017, 38(23):3354-3356.
PDF(1649 KB)
